EndoGI Provides Better Future for Stenting Procedures

Share

 

EndoGI Medical is a privately-owned Israeli company, backed by NGTVenture.  The product it is developing – the EndoGI system, enables insertion and placement of two plastic stents or more in the common bile and hepatic ducts and in the ureter with one passage of the delivery system while securing and maintaining access of the guide wire at the targeted anatomical site.

The Need

 

Blockage of the Bile duct, pancreas and in the ureters.  In case of stenosis as a result of cancer/injury/Inflammation/Cholangitis or Gallstones there is an urgent need in using stent for allow drainage.

The Product

 

Company’s main focus is on developing a fully pre-mounted system included the delivery system and the stents.

The Market

 

The Gastroenterologists performing ERCP and Endourologist performing  stenting procedures.
The Pancreatic and Biliary Stents Market (Metal + Plastic stents) Valued $257 Million in 2018, and growing to $371 Million in 2023. 1,000,000 (2018) Plastic Stents are inserted annually globally.
The global ureteral stents market was valued at $304 million in 2016, and is estimated to reach $449 million by 2023, growing at a CAGR of 5.7% from 2017 to 2023

The Team

 

  • Omri Naveh, CEO
    • Omri Naveh has experience in R&D and Engineering management position.
    • Omri led products through FDA approvals, NPI processes and mass production.
    • Previous companies: Lumenis and ETView

 

  • Elad Einav, Co-Founder, Director & Chief Technology Officer
    • Elad Einav has over 10 years of experience in R&D, Clinical & Regulatory and management positions.
    • Elad led products through FDA and CE approvals to scalability and commercialization
    • (CEO at MediBrane, Biovo)

 

  • Ronny Barak, Co-Founder, Director & Strategic Business Development
    • Ronny Barak has over 20 years of experience in the Life Science industry
    • Ronny led as CEO in medical device companies to acquisition, strategic partnership and IPO
    • (CEO at Disc-O-Tech, CollPlant, EndoGun-IBI)

Contact for interested investors

Omri Naveh – CEO of EndoGI Medical